Press Releases

Date Title and Summary Additional Formats
Toggle Summary Omnicell Reports Fiscal Year and Fourth Quarter 2019 Results
Record annual GAAP and non-GAAP revenues of $897.0 million Record 2019 GAAP net income per diluted share of $1.43 Record 2019 non-GAAP net income per diluted share of $2.81 Record ending product backlog of $588 million MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Feb. 6, 2020-- Omnicell, Inc....
View HTML
Toggle Summary Omnicell to Release Fourth Quarter 2019 Earnings Results on February 6, 2020
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Jan. 30, 2020-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, February 6, 2020 , to discuss the Company’s Fourth Quarter...
View HTML
Toggle Summary Omnicell to Present at the 38th Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 18, 2019-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter Kuipers ,...
View HTML
Toggle Summary Omnicell to Present Strategic Priorities and Long-Term Financial Targets at Annual Innovation Day for Investors and Analysts
Company Focused on Advancing Capabilities in Automation, Intelligence and Services to Create Zero-Error, Fully Automated Medication Management Infrastructure MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Dec. 10, 2019-- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions...
View HTML
Toggle Summary Omnicell Announces Annual Innovation Day for Investors and Analysts
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Nov. 19, 2019-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced they will host an Investor and Analyst meeting at the Annual ASHP Midyear Meeting...
View HTML
Toggle Summary Omnicell Achieves Record Revenue in the Third Quarter 2019
Record GAAP and non-GAAP revenues of $228.8 million , up 12.0% year-over-year GAAP net income per diluted share of $0.46 , up 39.4% year-over-year Record non-GAAP net income per diluted share of $0.76 , up 20.6% year-over-year MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 24, 2019-- Omnicell, Inc....
View HTML
Toggle Summary Omnicell to Release Third Quarter 2019 Earnings Results on October 24, 2019
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Oct. 17, 2019-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 24, 2019 , to discuss the Company’s Third Quarter...
View HTML
Toggle Summary Omnicell to Present at the 2019 Wells Fargo Securities Healthcare Conference
MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)--Aug. 27, 2019-- Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that Randall Lipps , founder, chairman, president and CEO, and Peter Kuipers ,...
View HTML
Toggle Summary Omnicell Reports Results for First Quarter 2019
GAAP and non-GAAP revenues of $202.5 million, up 10.9% year-over-year GAAP net income per diluted share of $0.08, up 14.3% year-over-year Non-GAAP net income per diluted share of $0.61, up 110.3% year-over-year MOUNTAIN VIEW, Calif. , April 25, 2019 /PRNewswire/ -- Omnicell, Inc....
View HTML
Toggle Summary Omnicell to Release First Quarter 2019 Earnings Results on April 25, 2019
MOUNTAIN VIEW, Calif. , April 18, 2019 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, April 25, 2019 , to discuss the Company's First...
View HTML